NCT00978887

Retorna Facial Cream in the Treatment of Facial Wrinkles

Efficacy of Retorna Facial Cream Usage in the Treatment of Facial Wrinkles

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 148 (estimated)
• Sponsor: Catalysis SL · Industry
• Sex: Female
• Age: 20 Years – 60 Years
• Healthy volunteers: Not accepted

Summary

The purpose of the study is to assess the efficacy of Retorna facial cream usage in the reduction or total correction of facial wrinkles. The duration of this double-blind placebo controlled phase 3 clinical trial will be 4 weeks. The estimated number of women to be recruited and randomized for the study is 148. Occurrence of adverse effects will also be evaluated.

Conditions

• Facial Wrinkles

Interventions

Type	Name	Description
OTHER	Retorna	Dosage commensurate with surface to be treated, Retorna facial cream (Topical use), twice a day, for 4 weeks.
OTHER	Placebo	Dosage commensurate with surface to be treated, Placebo facial cream (Topical use), twice a day, for 4 weeks

Timeline

• Start date: 2009-10-01
• Primary completion: 2010-05-01
• Completion: 2010-05-01
• First posted: 2009-09-17
• Last updated: 2010-05-18

Locations

1 site across 1 country: Cuba